2Shen DY, Fang ZX, You P, et al. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma[J]. Liver Int, 2010, 30(1): 119- 125.
3Masuda TA, Inoue H, Nishida K, et al. Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma[J]. Clin Cancer Res, 2003, 9(15): 5693-5698.
4Liu AW, Cai J, Zhao XL, et al. ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth[J]. Clin Cancer Res, 2011, 17(4): 710- 720.
5Zhu B, Chen Z, Cheng X, et al. Induction of TRAG-3 expression in A549 lung adenocarcinoma cell line by 5-aza-2' deoxyazacytidine[J]. Lung Cancer, 2002, 38(3): 321-322.
6Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens[J]. Nat Med, 1998, 4(7): 844-847.
7Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures[J]. J Viral Hepat, 2004, 11(2): 97-107.
